High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Cote d'Ivoire, 2018 to 2020 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Cancer Année : 2023

High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Cote d'Ivoire, 2018 to 2020

Simon P Boni
  • Fonction : Auteur
Vanessa Tenet
  • Fonction : Auteur
Apollinaire Horo
  • Fonction : Auteur
Danielle a M Heideman
  • Fonction : Auteur
Maaike C G Bleeker
  • Fonction : Auteur
Aristophane Tanon
  • Fonction : Auteur
Boston Mian
  • Fonction : Auteur
Isidore D Mohenou
  • Fonction : Auteur
Tarik Gheit
  • Fonction : Auteur
Judith Didi-Kouko Coulibaly
  • Fonction : Auteur
Boris K Tchounga
  • Fonction : Auteur
Innocent Adoubi
  • Fonction : Auteur
Gary M Clifford
  • Fonction : Auteur

Résumé

As human papillomavirus (HPV) immunisation and HPV-based cervical cancer (CC) screening programmes expand across sub-Saharan Africa, we investigated the potential impact of human immunodeficiency virus (HIV) status on high-risk (HR)-HPV distribution among women with CC in Cote d'Ivoire. From July 2018 to June 2020, paraffin-embedded CC specimens diagnosed in Abidjan, Cote d'Ivoire were systematically collected and tested for HR-HPV DNA. Type-specific HR-HPV prevalence was compared according to HIV status. Of the 170 CC specimens analysed (median age 52 years, interquartile range: [43.0-60.0]), 43 (25.3%) were from women living with HIV (WLHIV) with a median CD4 count of 526 [373-833] cells/mm(3) and 86% were on antiretroviral therapy (ART). The overall HR-HPV prevalence was 89.4% [95% CI: 84.7-94.1]. All were single HR-HPV infections with no differences according to HIV status (P = .8). Among HR-HPV-positive CC specimens, the most prevalent HR-HPV types were HPV16 (57.2%), HPV18 (19.7%), HPV45 (8.6%) and HPV35 (4.6%), with no significant differences according to HIV status. Altogether, infection with HPV16/18 accounted for 71.1% [95% CI: 55.9-86.2] of CC cases in WLHIV vs 78.9% [95% CI: 71.3-86.5] in women without HIV (P = .3). The study confirms the major role of HPV16/18 in CC in Cote d'Ivoire and should support a regional scale-up of HPV16/18 vaccination programmes regardless of HIV status. However, vaccines targeting additional HR-HPV types, including HPV45 and HPV35, could further decrease future CC incidence in Cote d'Ivoire, both for WLHIV and women without HIV.
Fichier principal
Vignette du fichier
BPH_IntJCancer_2023_Boni.pdf (579.65 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04384266 , version 1 (10-01-2024)

Licence

Identifiants

Citer

Simon P Boni, Vanessa Tenet, Apollinaire Horo, Danielle a M Heideman, Maaike C G Bleeker, et al.. High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Cote d'Ivoire, 2018 to 2020. International Journal of Cancer, 2023, ⟨10.1002/ijc.34774⟩. ⟨hal-04384266⟩

Collections

IRD U1219
1 Consultations
5 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More